Tampa, Florida, United States – TheNewswire – February 28, 2022 – CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) announced today that Cam Birge has stepped down as CEO. Cam was an instrumental part in bringing Aurora to CTT Pharma. We appreciate his help and wish him well in the future.
Management will be looking to secure a sales-centric CEO as part of its new strategy to leverage and execute on its large portfolio of patents. The company is currently undergoing numerous changes and will be looking to keep Investors up-to-date to reflect its new vision.